Botanical species · safety record

Leonurus japonicus

The EFSA Compendium of Botanicals holds 7 constituent measurements for Leonurus japonicus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Leonurus japonicus Houtt.

7Constituent measurements
0Safety records
5Cited sources
199Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 199 licensed products naming Leonurus japonicus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh

Source material stated

  • Aerial parts
  • Dried aerial part(s)
  • Fruit
  • Herb
  • Herb (processed with wine)
  • Herb top
  • Herb(s)
  • Leaf

What the records describe

Constituents measured

  • Alkaloids2
  • Labdane diterpenes2
  • Stachydrine2
  • Coumarins1

Plant parts

  • Aerial part of plants4
  • Unspecified3

Preparations

  • Solvent extraction7

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsUnspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Labdane diterpenesUnspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsAerial part of plantsSolvent extraction0.3 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
CoumarinsUnspecifiedSolvent extractionChromatographic testsNo resolvable identifier
Labdane diterpenesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
StachydrineAerial part of plantsSolvent extraction≥ 0.1 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
StachydrineAerial part of plantsSolvent extraction≤ 0.2 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. He, C.-J., Peng, C., Dai, O., Yang, L., Liu, J., Guo, L., Xiong, L., Liu, Z.-H. Chemical constituents from Leonurus japonicus Injection. Chinese traditional and herbal drugs, 2014, vol. 45, no. 21, p. 3048-3052. DOI
  2. Chao, Zhi., Ma, Li-ling., Zhou, Xiu-jia. Determination of stachydrine and leonurine in Herba Leonuri by ion- pair reversed-phase high-performance liquid chromatography . . Di 1 jun yi da xue xue bao = academic journal of the first medical college of pla, 2004, vol. 24, no. 11, p. 1223-6.
  3. Moon, Hyung-In. Three Diterpenes from Leonurus japonicus Houtt Protect Primary Cultured Rat Cortical Cells from Glutamate-induced Toxicity . Phytotherapy research, 2010, vol. 24, no. 8, p. 1256-1259. DOI
  4. Seo, Hyun Kyu., Kim, Ju Sun., Kang, Sam Sik. Labdane Diterpenes and Flavonoids from Leonurus japonicus. Helvetica chimica acta, 2010, vol. 93, no. 10, p. 2045-2051.
  5. Yang, Huai., Zhou, Qin-mei., Peng, Cheng., Liu, Lu-si., Xie, Xiao-fang., Xiong, Liang., Liu, Zhao-hua. Coumarins from Leonurus japonicus and their anti-platelet aggregative activity . . Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2014, vol. 39, no. 22, p. 4356-9.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue